86 related articles for article (PubMed ID: 33691434)
1. Influence of postoperative adjuvant transarterial chemoembolization on the prognosis of early-stage intrahepatic cholangiocarcinoma: a single center study.
Liu G; Guo W; Wang H; Liu W; Lei L; Xie Q; Li X; Zou S; Wang P; Zhou H; Hu H
Ann Palliat Med; 2021 Apr; 10(4):3673-3683. PubMed ID: 33691434
[TBL] [Abstract][Full Text] [Related]
2. Systemic chemotherapy plus transarterial chemoembolization versus systemic chemotherapy alone for unresectable intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study.
Jiang N; Zhang Z; Yin X; Qiu H; Yan W; Hao Y; Yang W; Li H; Xu A; Mu K
Radiol Med; 2024 Apr; 129(4):631-642. PubMed ID: 38355907
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy is superior to transarterial chemoembolization as adjuvant therapy after narrow-margin hepatectomy in patients with hepatocellular carcinoma: A single-center prospective randomized study.
Bai T; Tang ZH; Wang XB; Chen J; Ye JZ; Lu SL; Wei M; Wu FX; Li LQ
Langenbecks Arch Surg; 2024 Mar; 409(1):97. PubMed ID: 38488934
[TBL] [Abstract][Full Text] [Related]
4. Tumor burden score and carcinoembryonic antigen predict outcomes in patients with intrahepatic cholangiocarcinoma following liver resection: a multi‑institutional analysis.
Fu J; Zheng L; Tang S; Lin K; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Wang K; Li H; Zeng Y
BMC Cancer; 2024 Mar; 24(1):358. PubMed ID: 38509498
[TBL] [Abstract][Full Text] [Related]
5. Postoperative Prognosis of Non-alcoholic Fatty Liver Disease-Associated Intrahepatic Cholangiocarcinoma: a Multi-center Propensity Score Matching Analysis.
Yu Q; Lei Z; Ma W; Yang F; Tang H; Xiao Q; Tang X; Si A; Yang P; Zhou N; Cheng Z
J Gastrointest Surg; 2023 Nov; 27(11):2403-2413. PubMed ID: 37582919
[TBL] [Abstract][Full Text] [Related]
6. Construction of a prediction model for postoperative prognosis in patients with resectable cholangiocarcinoma based on silence information regulator 2 expression.
Wang W; Ji W; Lyu Z; Sun W; Shao Y; Liu J; Yang Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 53(1):98-107. PubMed ID: 38105682
[TBL] [Abstract][Full Text] [Related]
7. Preoperatively elevated RDW-SD and RDW-CV predict favorable survival in intrahepatic cholangiocarcinoma patients after curative resection.
Li X; Chen Q; Bi X; Zhao J; Li Z; Zhou J; Huang Z; Zhang Y; Mao R; Zhao H; Cai J
BMC Surg; 2021 Mar; 21(1):105. PubMed ID: 33648470
[TBL] [Abstract][Full Text] [Related]
8. Impact of sarcopenia on postoperative outcomes after hepatectomy in older patients with intrahepatic cholangiocarcinoma: A multicentre cohort study.
Zhao Z; Bo Z; Ye N; Dong Y; Xu Y; Wang B; Yang F; Liu L; Liu Z
Liver Int; 2024 Jan; 44(1):155-168. PubMed ID: 37804070
[TBL] [Abstract][Full Text] [Related]
9. The prognostic nutritional index as a predictor of efficacy and early recurrence for adjuvant transarterial chemoembolization in hepatocellular carcinoma.
Pan X; Hu E; Zhou Y; Li L; Huang X; Cai Z
Clin Res Hepatol Gastroenterol; 2024 Apr; 48(6):102344. PubMed ID: 38641249
[TBL] [Abstract][Full Text] [Related]
10. Postoperative adjuvant transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond the Milan criteria: a retrospective analysis.
Dong ZR; Zhang PF; Wang CH; Zhang C; Cai JB; Shi GM; Ke AW; Sun HC; Qiu SJ; Zhou J; Fan J
Am J Cancer Res; 2015; 5(1):450-7. PubMed ID: 25628953
[TBL] [Abstract][Full Text] [Related]
11. Real-world experience of postoperative adjuvant chemoimmunotherapy in patients with perihilar cholangiocarcinoma at high risk of recurrence.
Liu QQ; Shi XD; Ye YF; Tang QB; Lin HM; Yu XH; Zhang R; Liu C
Cancer Immunol Immunother; 2023 Jun; 72(6):1753-1761. PubMed ID: 36648557
[TBL] [Abstract][Full Text] [Related]
12. The Potential Role of Adjuvant Chemoradiotherapy in Patients with Microscopically Positive (R1) Surgical Margins after Resection of Cholangiocarcinoma.
Palloni A; Bisello S; Maggio I; Massucci M; Galuppi A; Di Federico A; Rizzo A; Ricci AD; Siepe G; Morganti AG; Brandi G; Frega G
Curr Oncol; 2023 May; 30(5):4754-4766. PubMed ID: 37232816
[TBL] [Abstract][Full Text] [Related]
13. Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma.
Xin HY; Zou JX; Sun RQ; Hu ZQ; Chen Z; Luo CB; Zhou ZJ; Wang PC; Li J; Yu SY; Liu KX; Fan J; Zhou J; Zhou SL
J Gastroenterol; 2024 May; 59(5):411-423. PubMed ID: 38461467
[TBL] [Abstract][Full Text] [Related]
14. Surgical management of recurrent intrahepatic cholangiocarcinoma: predictors, adjuvant chemotherapy, and surgical therapy for recurrence: A multi-institutional study by the Kyushu Study Group of Liver Surgery.
Yamashita YI; Shirabe K; Beppu T; Eguchi S; Nanashima A; Ohta M; Ueno S; Kondo K; Kitahara K; Shiraishi M; Takami Y; Noritomi T; Okamoto K; Ogura Y; Baba H; Fujioka H
Ann Gastroenterol Surg; 2017 Jun; 1(2):136-142. PubMed ID: 29863136
[TBL] [Abstract][Full Text] [Related]
15. Application of dynamic contrast enhanced ultrasound analysis in predicting early response to systemic therapy of intrahepatic cholangiocarcinoma.
Lu XY; Jiang J; Chen S; Qiu YJ; Wang Y; Cheng J; Xu XL; Dong Y; Wang WP
Eur J Radiol; 2024 Jun; 175():111439. PubMed ID: 38547743
[TBL] [Abstract][Full Text] [Related]
16. Long-term prognosis of patients with gallbladder carcinoma after curative-intent resection based on changes in the ratio of carbohydrate antigen 19-9 to total bilirubin (CA19-9/TB): a multicenter retrospective cohort study.
Li XL; Liu ZP; Su XX; Gong Y; Yang YS; Zhao XL; Li ZM; Ding JJ; Zhu Y; Yin DL; Yu C; Zhou JX; Zhang D; Ding R; Chen W; Cheng Y; Yue P; Wang ZR; Zhang YQ; Jiang Y; Yin XY; Bai J; Dai HS; Lau WY; Chen ZY;
Int J Surg; 2024 Apr; ():. PubMed ID: 38626431
[TBL] [Abstract][Full Text] [Related]
17. Relationship between plasma cell-free DNA (cfDNA) and prognosis of TACE for primary hepatocellular carcinoma.
Ma K; Liu J; Wang Y; Zhong Y; Wu Z; Fan R; Guo S
J Gastrointest Oncol; 2020 Dec; 11(6):1350-1363. PubMed ID: 33457006
[TBL] [Abstract][Full Text] [Related]
18. Predicting prognosis in intrahepatic cholangiocarcinoma by the histopathological features.
Liu H; Lan T; Cai YS; Lyu YH; Zhu J; Xie SN; Hu FJ; Liu C; Wu H
Asian J Surg; 2024 Apr; ():. PubMed ID: 38604849
[TBL] [Abstract][Full Text] [Related]
19. Anatomical sectionectomy based on Takasaki's segmentation for solitary intrahepatic cholangiocarcinoma: a propensity-matched analysis.
Wang WQ; Li J; Lv X; Wang JL; Zhang EL; Zhang BH; Xiao ZY; Liang BY; Huang ZY
HPB (Oxford); 2024 Feb; ():. PubMed ID: 38485565
[TBL] [Abstract][Full Text] [Related]
20. The Clinical Association Between the Inflammation-Nutritional Condition and Prognosis of Locally Advanced Intrahepatic Cholangiocarcinoma After R0 Resection: Evidence from Competing Risk and Propensity Matching Analysis.
Huang G; Xi P; Yao Z; Zhao C; Li X; Chen Z; Lin X
J Inflamm Res; 2024; 17():2787-2799. PubMed ID: 38737115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
